Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.

Kedhi E, Fabris E, van der Ent M, Buszman P, von Birgelen C, Roolvink V, Zurakowski A, Schotborgh CE, Hoorntje JCA, Eek CH, Cook S, Togni M, Meuwissen M, van Royen N, van Vliet R, Wedel H, Delewi R, Zijlstra F.

BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.

2.

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.

Arroyo DA, Schukraft S, Kallinikou Z, Stauffer JC, Baeriswyl G, Goy JJ, Togni M, Cook S, Puricel S.

Open Heart. 2018 Jan 3;5(1):e000624. doi: 10.1136/openhrt-2017-000624. eCollection 2018.

3.

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).

Vlachojannis GJ, Smits PC, Hofma SH, Togni M, Vázquez N, Valdés M, Voudris V, Slagboom T, Goy JJ, den Heijer P, van der Ent M.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1215-1221. doi: 10.1016/j.jcin.2017.02.029. Epub 2017 May 31.

4.

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial.

Arroyo D, Gendre G, Schukraft S, Kallinikou Z, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Togni M, Cook S, Puricel S.

Int J Cardiol. 2017 Sep 15;243:121-125. doi: 10.1016/j.ijcard.2017.05.053. Epub 2017 May 12.

PMID:
28576627
5.

Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.

Welsh SJ, Churchman ML, Togni M, Mullighan CG, Hagman J.

Leukemia. 2018 Jan;32(1):38-48. doi: 10.1038/leu.2017.166. Epub 2017 May 30.

6.

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.

Kallinikou Z, Berger A, Ruchat P, Khatchatourov G, Fleisch I, Korkodelovic B, Henchoz E, Marti RA, Cook S, Togni M, Goy JJ.

Arch Cardiovasc Dis. 2017 Jun - Jul;110(6-7):389-394. doi: 10.1016/j.acvd.2016.10.005. Epub 2017 Apr 19.

7.

NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.

Bisio V, Zampini M, Tregnago C, Manara E, Salsi V, Di Meglio A, Masetti R, Togni M, Di Giacomo D, Minuzzo S, Leszl A, Zappavigna V, Rondelli R, Mecucci C, Pession A, Locatelli F, Basso G, Pigazzi M.

Leukemia. 2017 Apr;31(4):974-977. doi: 10.1038/leu.2016.361. Epub 2016 Nov 28. No abstract available.

PMID:
27890935
8.

Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.

Masetti R, Castelli I, Astolfi A, Bertuccio SN, Indio V, Togni M, Belotti T, Serravalle S, Tarantino G, Zecca M, Pigazzi M, Basso G, Pession A, Locatelli F.

Oncotarget. 2016 Aug 30;7(35):56746-56757. doi: 10.18632/oncotarget.10778.

9.

Radiation Exposure of the Operator During Coronary Interventions (from the RADIO Study).

Kallinikou Z, Puricel SG, Ryckx N, Togni M, Baeriswyl G, Stauffer JC, Cook S, Verdun FR, Goy JJ.

Am J Cardiol. 2016 Jul 15;118(2):188-94. doi: 10.1016/j.amjcard.2016.04.045. Epub 2016 May 5.

PMID:
27239022
10.

Heart rate never lies: interventional cardiologist and Braude's quote revised.

Cook S, Stauffer JC, Goy JJ, Graf D, Puricel S, Frobert A, Muller O, Togni M, Arroyo D.

Open Heart. 2016 Jan 11;3(1):e000373. doi: 10.1136/openhrt-2015-000373. eCollection 2016.

11.

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial.

Kallinikou Z, Arroyo D, Togni M, Lehman S, Corpataux N, Cook M, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Puricel SG, Cook S.

Swiss Med Wkly. 2016 Jan 14;146:w14274. doi: 10.4414/smw.2016.14274. eCollection 2016.

12.

Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT).

Puricel S, Kallinikou Z, Espinola J, Arroyo D, Goy JJ, Stauffer JC, Baeriswyl G, Smits PC, Cook S, Togni M.

Int J Cardiol. 2016 Jan 1;202:525-31. doi: 10.1016/j.ijcard.2015.09.085. Epub 2015 Sep 26.

PMID:
26440470
13.
14.

Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing.

Togni M, Masetti R, Pigazzi M, Astolfi A, Zama D, Indio V, Serravalle S, Manara E, Bisio V, Rizzari C, Basso G, Pession A, Locatelli F.

J Hematol Oncol. 2015 Jun 12;8:69. doi: 10.1186/s13045-015-0167-8.

15.

The adhesion- and degranulation-promoting adaptor protein and its role in the modulation of experimental autoimmune encephalomyelitis.

Engelmann S, Togni M, Kliche S, Reinhold D, Schraven B, Reinhold A.

Crit Rev Immunol. 2015;35(1):1-14. Review.

PMID:
25746044
16.

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.

Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, Muller O, Allard L, Stauffer JC, Togni M, Goy JJ, Cook S.

J Am Coll Cardiol. 2015 Mar 3;65(8):791-801. doi: 10.1016/j.jacc.2014.12.017.

17.

[Thoughts on a regional or national single-payer system in Switzerland].

Togni M.

Rev Med Suisse. 2014 Oct 8;10(445):1895. French. No abstract available.

PMID:
25417368
18.

A case of hyperemesis in bulimia nervosa.

Pedrolli C, Sacchi MC, Togni M, Cereda E.

Int J Eat Disord. 2015 May;48(4):446-8. doi: 10.1002/eat.22315. Epub 2014 Jun 5.

PMID:
24902945
19.

Ten-year clinical follow-up after sirolimus-eluting stent implantation.

Palhais N, Arroyo D, Lehmann S, Togni M, Kaufmann U, Puricel SG, Stauffer JC, Goy JJ, Cook S.

Am Heart J. 2014 Jun;167(6):893-9. doi: 10.1016/j.ahj.2013.12.013. Epub 2014 Jan 4.

PMID:
24890540
20.

Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children.

Masetti R, Rondelli R, Fagioli F, Mastronuzzi A, Pierani P, Togni M, Menna G, Pigazzi M, Putti MC, Basso G, Pession A, Locatelli F.

Haematologica. 2014 Aug;99(8):e127-9. doi: 10.3324/haematol.2014.106526. Epub 2014 May 16. No abstract available.

Supplemental Content

Support Center